Skip Ribbon Commands
Skip to main content
Translate
Translate
menu iconMenu
search iconSearch

Halpert Named Associate Dean for Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego

 

May 19, 2008  |  

James R. Halpert, Ph.D. joined the Skaggs School of Pharmacy and Pharmaceutical Sciences in March as professor and Associate Dean for Scientific Affairs.  In this new position, Halpert will be instrumental in helping the School, founded in 2001, build its scientific base, recruit new faculty, and develop new scientific initiatives and partnerships on the UC San Diego campus and across the La Jolla mesa.

“Dr. Halpert will play a key role in developing programs and recruiting faculty in key positions for the Skaggs School, including pharmaceutics, pharmacogenomics and other fields related to drug discovery and development,” said Palmer Taylor, Ph.D., Dean of the Skaggs School, Associate Vice Chancellor for Health Sciences and Sandra & Monroe Trout Professor of Pharmacology.  “We are extremely pleased to have as our associate dean a stellar researcher with the breadth of experience that he brings to this position.”

James Halpert, Ph.D.
James R. Halpert, Ph.D.

Halpert brings with him a major research program on the structure and function of enzymes involved in drug metabolism and disposition.  In his capacity as associate dean, he will help in developing the School’s new Pharm.D./Ph.D. program and forging national and international research and academic partnerships.

Halpert states that the quality of the faculty at the Skaggs School of Pharmacy and Pharmaceutical Sciences, as well as the opportunity to make his mark with a new and thriving school of pharmacy were the main reasons he came to UC San Diego.

“I am extremely impressed by the caliber of research and teaching being done by the faculty at this institution, and am happy to be part of what I regard as one of the top schools of pharmacy in the country,” he said.  Halpert added that he is excited about the challenge of building ties between the School and the community, particularly San Diego’s biotech and pharmaceutical industries.

Before coming to UCSD, Halpert was at the University of Texas Medical Branch where he served as professor and chairman of the Department of Pharmacology and Toxicology, director of its NIEHS Center and interim director of the Sealy Center for Environmental Health and Medicine.  He also held the Mary Gibbs Jones Distinguished Chair in Environmental Toxicology.  

Halpert returns to the UC System, where he earned a B.A. in Scandinavian Languages from UCLA.  He received a Ph.D. in biochemistry from Uppsala University and a master’s degree in toxicology from the Karolinska Institute, Stockholm. He was a member of the National Institutes of Health’s Pharmacology Study Section from 1992 to1995 and served as chairman from 1993 to1995. A former editor of Drug Metabolism and Disposition, Halpert’s research for the past 30 years has focused on the structure and function of drug-metabolizing enzymes called cytochromes P450, which are major determinants of individual responses to medications.

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu




Media Contact

Related News

4/22/2015
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year ...
4/20/2015
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and p ...
4/20/2015
A decrease in the amount of time spent eating and an increase in overnight fasting reduces glucose levels and may reduce the risk of breast cancer among women, report University of California, San Die ...
4/20/2015
The threat of falsified medications, also referred to as counterfeit, fraudulent, and substandard, can be quite real, yet the full scope and prevalence of the problem is poorly understood, say researc ...
4/17/2015
Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices us ...
4/16/2015
The increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation t ...
4/16/2015
An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardi ...
4/13/2015
About one quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to a new study by researchers at Universit ...


Share This Article



Follow Us: